1 / 25

THE ROLE OF UNICEF SUPPLY DIVISION

UN Prequalification: UNICEF Perspective 5 th UN Prequalification stakeholders meeting 11th February 2009. THE ROLE OF UNICEF SUPPLY DIVISION. Maintain the highest ethical standards for procurement.

davin
Télécharger la présentation

THE ROLE OF UNICEF SUPPLY DIVISION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. UN Prequalification:UNICEF Perspective5th UN Prequalification stakeholders meeting11th February 2009

  2. THE ROLE OF UNICEF SUPPLY DIVISION Maintain the highest ethical standards for procurement. Provide technical support to UNICEF offices and Procurement Services partners globally. Share procurement know-how with development partners. Innovate to find ever-better supply solutions for children. Oversee UNICEF’s global procurement and logistics operation. Procure supplies on behalf of UNICEF and Procurement Services partners Ensure that high quality, good value supplies reach children and their families quickly.

  3. Procurement by UNICEF 2000-2009 • Procurement of PQ products in 2009 • 2.96 billion doses of vaccines on behalf of 88 countries • ARVs for estimated 780,000 patients for one year • 30 million ACT treatments • Total value USD 915 million Scale-up of interventions for which UNICEF procures supplies has been linked to global funding efforts by partners (GAVI, WB, GFATM, UNITAID, Governments) and WHO Prequalification

  4. The Prequalification Programme addresses priority needs in public health • System for independent assessment that follows international standards • Prioritization that focuses on diseases of interest • Enabler for countries and programmes to access quality products • Supports countries to strengthen the capacities of their own NRAs • Supports the creation of competitive and healthy markets.

  5. PREQUALIFICATION OF MEDICINES

  6. Procurement of medicines.Main groups by value WHO PQ covers ARVs and ACTs, limited number of products for other groups. Majority of non-ARV and non-ACTs products evaluated by UNICEF (WHO GMP, technical dossiers)

  7. Antiretroviral medicinesUNICEF SUPPLIER BASE 2004-2008 And over 25 products approved in 2009 which will be part of 2009 RFP

  8. Significant increase in number of prequalified products for main first line treatments 7 11 5 8 8 7 9 4 9 6 5 7 4 3 6 3 4 5 2 3 2 3 2 3 2 1 Numbers in graph represent products in WHO PQ list (cumulative)

  9. UNICEF price trend and supplier base for two key first line ARVs * d4T+3TC+NVP refers to d4T 30mg FDC only

  10. ACTs • Procured through a joint tender with WHO • Increase in prequalification of products in 2008-2009 has allowed to prioritize WHO PQ status as criteria for award. Strategy follows shared objectives with partners (WHO, UNITAID). • In 2009, WHO Prequalified ACTs represented 87% of treatments procured. • Gap in PQ of ACTs containing SP and Mefloquine, and need to prioritize evaluation of new ACTs • Gap also in PQ and SRA registration of other antimalarials (arthemeter inj, quinine) that affects GFATM programmes

  11. PREQUALIFICATION OF MEDICINES: OPPORTUNITIES • Coordination in the preparation of priority lists (REOI) with procurement agents and donors to address gaps in access and enable market shaping • Increase quality of submissions and review time for priority products (TA, option for review at various stages of dossier preparation?) • Establishment of mechanism to enable recognition of WHO PQ by NRAs in registration process. • Increased coordination with SRAs to enable inclusion of products in WHO list. • Supporting mechanisms or alternative approach for products for which there is limited hope of recommendation through current PQ process (risk-benefit approach).

  12. PREQUALIFICATION OF VACCINES

  13. Value per year for EPI Vaccines, OPV, New vaccines and others

  14. WHO Prequalification system for vaccines WHO Prequalification system has been a key component of UNICEF’s procurement strategies developed to support vaccine security and develop new markets (GAVI) Priorities for prequalification efforts established to address programme needs (e.g polio eradication, introduction of HepB, Hib and Pneumo vaccines) Independence from procurement roles strengthens integrity of both functions

  15. The growth in demand in DTP-HepB/Hib, supported by GAVI funding, has transitioned the DTP market, creating the sustainable market… All offers for DTP-HepB/Hib for pre-qualified and non pre-qualified products Market Shaping - Recently Introduced vaccines

  16. Marketing shaping of the Pentavalent market Millions of Doses Pentavalent Market development showed significant scale up in 2009

  17. Marketing shaping of the Pentavalent market Millions of Doses 2010 – 2012 Forecast Quantities are at similar levels to 2009 (excluding India demand)

  18. Marketing shaping of the Pentavalent market Millions of Doses The supply base of WHO PQ vaccines has increased in response to increased demand, showing a positive development in the supply base with additional products in the pipeline

  19. Marketing shaping of the Pentavalent market Millions of Doses Flexibility to switch between available presentations and new products was also established. The WAP has declined to < $3.00/ dose with anticipated declines with additional awards, switching to multi dose presentations or new products

  20. PREQUALIFICATION OF VACCINES: OPPORTUNITIES Increased resources to meet the increased demand in terms of number of products and changing technology. Expand information available on product characteristics and limitation of recommendations. Strengthening linkages with NRAs to ensure quality of products procured by regional/national agencies.

  21. PREQUALIFICATION OF DIAGNOSTICS

  22. DIAGNOSTICSUNICEF PROCUREMENT 2006-2008 Trends • Continued growth in HIV, HBV and Malaria rapid test kits. • Value of procurement for test kits was US19M in 2009, up from 16M in 2008. • Growth in Syphilis test kits, both rapid and lab, linked to use in ante-natal screening. • Viral load / EID steep increase – introduction of kits with UNITAID support

  23. PREQUALIFICATION OF DIAGNOSTICS: OPPORTUNITIES • Sustain and increase the momentum in PQ activities and push for the completion of assessment of appropriate product groups (e.g. Malaria RDTs, viral load). • Coordination in preparation on priority lists • Expansion of information available on product characteristics, scope of assessment and assessment criteria • Increase role in coordination of technical consultations to generate specifications that can guide procurement.

  24. SUMMARY • The Prequalification Programme is central in addressing global public health needs • Ensuring access to quality products • Enabling shaping of markets through scale-up efforts • Interest of UNICEF in contributing to preparation on priority lists • Key role in increasing capacity of NRAs, necessary to reduce need of PQ system • Increase role in coordination of technical consultations to generate specifications that can guide selection and procurement (diagnostics) .

  25. UNICEF VACCINES Thank You!

More Related